Author Archives: zymecom

← Older posts

Source BioScience invest €585,000 in stability storage with new state-of-the-art microbiology and sterility testing labs

Posted on by zymecom

New facilities expand services offering to Irish and International customers Nottingham, UK, 16 September 2019: Source Bioscience, an international provider of integrated laboratory services and products, today announced it has invested €585,000 in microbiology and sterility testing labs at its … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

Mologic and University College London Hospitals collaborating in major clinical trial for early detection of sepsis

Posted on by zymecom

Study aims to develop a rapid point-of-care diagnostic based on multiple biomarkers to detect emergent sepsis Observational study led by Mervyn Singer, Professor of Intensive Care Medicine and Dr David Brealey, Consultant in Intensive Care Bedfordshire, UK, 13 September 2019: … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

BIA Separations introduces Cornerstone AAV Process Development Service to accelerate gene therapy production

Posted on by zymecom

BIA Separations introduces Cornerstone AAV Process Development Service to accelerate gene therapy production CORNERSTONE program integrates process development expertise and novel technology to remove development bottlenecks in the manufacture of Gene Therapy Medicinal Products (GTMPs) Portfolio includes novel CIMasphere™ technology … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

FUJIFILM Irvine Scientific Launches BalanCD Gal Supplement for biotherapeutic development

Posted on by zymecom

Delivers enhanced galactosylation for improved protein quality, and antibody binding and function  SANTA ANA, California, 10 September, 2019: FUJIFILM Irvine Scientific, Inc., a world leader in the optimization, development and manufacture of cell culture media and industrial cell culture solutions, … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

Gyros Protein Technologies introduces Gyrolab p24 Kit to support the cell and gene therapy market

Posted on by zymecom

Ready-to-use kit enables lentivirus titer determinations during the manufacture of lentivirus vectors Uppsala, Sweden, 09 September 2019: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced the introduction of … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

Mogrify appoints Dr. Jane Osbourn, OBE as Chair

Posted on by zymecom

Cambridge, UK, 9th September 2019: Mogrify Ltd (Mogrify), a UK company aiming to transform the development of cell therapies, today announced the appointment of Dr. Jane Osbourn, OBE as Chair of the Board. In addition to this role, Dr. Osbourn … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

Sphere Fluidics introduces Cyto-Cellect Human IgGK Detection Kit

Posted on by zymecom

First in a new range to advance identification and selection of cells with the highest productivity Assay-ready reagent kit to reduce timelines and enhance efficiency in cell line development Cambridge, UK, 9 September 2019: Sphere Fluidics, a company commercializing single … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

Owlstone Medical Announces Advancements in Breath Biopsy Platform Including Launch of Next Generation ReCIVA Breath Sampler and CASPER Portable Air Supply

Posted on by zymecom

Cambridge, UK, 05 September, 2019: Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the introduction of a new ReCIVA® Breath Sampler and CASPERTM Portable Air Supply, designed to support … Continue reading

Posted in News from Zyme and the companies we work with | Comments Off on Owlstone Medical Announces Advancements in Breath Biopsy Platform Including Launch of Next Generation ReCIVA Breath Sampler and CASPER Portable Air Supply

Gyros Protein Technologies introduces PurePep Chorus automated peptide synthesizer

Posted on by zymecom

Flexible, modular system, designed for 21CFR Part 11 compliance Delivers high purity, productivity and yield for simple to complex peptides Uppsala, Sweden, and Tucson, AZ, USA, 04 September 2019: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassay platforms … Continue reading

Posted in News from Zyme and the companies we work with | Comments Off on Gyros Protein Technologies introduces PurePep Chorus automated peptide synthesizer

Batavia Biosciences to deploy Horizon Discovery’s CHO cell technology to develop anti-Zika biotherapeutic with Vanderbilt University Medical Center and IDBiologics

Posted on by zymecom

Leiden, 03 September 2019: Today, Batavia Biosciences announced that the company has signed a license agreement to utilize Horizon Discovery’s GS knockout CHO K1 cell line expression system for the development of high yield antibody-expressing cell lines. Initially, Batavia will … Continue reading

Posted in News from Zyme and the companies we work with | Comments Off on Batavia Biosciences to deploy Horizon Discovery’s CHO cell technology to develop anti-Zika biotherapeutic with Vanderbilt University Medical Center and IDBiologics ← Older posts
  • People

    An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.

  • Keep in touch

    +44(0) 1223 968 920

    info@zymecommunications.com


     

  • Upcoming Events

    Zyme Communications will be providing support for its clients attending the following events:

    ELRIG Discovery Technologies 2019

    When: Thu September 26 09:00 - 18:00
    Where: Manchester, UK

    LSX World Congress USA

    When: Mon October 7 09:00 - Tue October 8 18:00
    Where: Boston, US